TIBER CREEK GROUP

Lobbying for EMD SERONO, INC. · Biopharmaceuticals.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Jan 20, 2026

Bills named in this filing 2

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

Health Issues

Issues related to reproductive healthcare and IVF.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.